Novel Indoline Derivatives Serotonergic Psychedelic Agents as 5-HT2A Agonists for Treating Psychosis, Mental Illness and CNS Disorders
Provided herein are novel indoline derivatives serotonergic psychedelic agents as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating psychosis, mental illness and central nervous system (CNS) disorders and processes for preparing such compounds.
Authors
- Ram W. Sabnis (ORCID: https://orcid.org/0000-0001-7289-0581)
- Anika R. Sabnis (ORCID: https://orcid.org/0009-0008-9940-6583)
Institutions
- Mayo Clinic (US)
Publication Details
- Journal
- ACS Medicinal Chemistry Letters
- Published
- 2026-04-27
- DOI
- https://doi.org/10.1021/acsmedchemlett.6c00208
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00